[Therapy of peripheral arterial occlusive diseases. Round table conference].
D000527:Alprostadil; D000800:Angioplasty, Balloon; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000925:Anticoagulants / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000628:therapy*; D001161:Arteriosclerosis / Q000628:therapy*; D001241:Aspirin / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D004691:Endarterectomy; D005081:Exercise Therapy; D005342:Fibrinolysis; D006801:Humans; D006949:Hyperlipidemias / Q000628:therapy; D006973:Hypertension / Q000628:therapy; D007261:Infusions, Intra-Arterial; D007383:Intermittent Claudication / Q000628:therapy; D011458:Prostaglandins E / Q000008:administration & dosage; D012702:Serotonin Antagonists / Q000627:therapeutic use; D013562:Sympathectomy; D013928:Thromboxane A2 / Q000037:antagonists & inhibitors
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D011458:Prostaglandins E; D012702:Serotonin Antagonists; D013928:Thromboxane A2; D004176:Dipyridamole; D000527:Alprostadil; D001241:Aspirin
Therapie peripherer arterieller Durchblutungsstörungen. Rundtischgespräch.